On the final days of her tenure as Federal Trade Commission chair, Lina Khan sits down with WSJ’s Damian Paletta to reflect ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks, ...
The Democratic enforcer significantly expanded the agency’s remit; now the new GOP administration will decide how to follow ...
While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from ...
While they didn't support Musk's allegations directly, the feds added weight to his interpretation of antitrust law.
Lina Khan, who was tapped by President Joe Biden to lead the FTC, is set to be replaced by President-elect Donald Trump’s ...
Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...